Biotech Co. Shareholders To Pay $3M To End SEC Fraud Suit
An ex-executive of RenovaCare and a shareholder have agreed to pay about $3 million to settle a U.S. Securities and Exchange Commission suit accusing them of artificially inflating the stock price...To view the full article, register now.
Already a subscriber? Click here to view full article